Contracts › 75N93020C00053
75N93020C00053: Covid-19. to Develop and Manufacture an Inactivated Virus Vaccine Using Blood Pathogen Reduction Technology.
Awarded to Colorado State University by National Institutes of Health (NIH).
$6.3Mobligated
$19.2Mpotential value
30 April 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93020C00053 |
|---|---|
| Awardee | Colorado State University |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AJ12 General Science and Technology R&D Services; General Science and Technology; Applied Research |
| Place of performance | CO |
| Offers received | 23 |
| Period of performance | 01 September 2020 to 30 April 2028 |
| Potential end | 30 April 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record